Navigation Links
ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
Date:7/29/2009

to join the ViroPharma investor conference call.

Alternatively, the live webcast of the conference call can be accessed via ViroPharma's website athttp://www.viropharma.com. Windows Media or Real Player will be needed to access the webcast. An audio archive will be available at the same address until August 14, 2009.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor [human]) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Disclosure Notice

Certai
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
2. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
3. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
4. ViroPharma to Present at Two May Healthcare Conferences
5. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
6. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
7. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
8. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
9. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
10. ViroPharma Provides Update on Vancocin(R)
11. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... ... The ZAC Foundation, a national leader in water safety education and drowning ... stay water safe with the help of a young polar bear named Zeke. ... follows Zeke’s water safety journey. Zeke, who is afraid of the water and ...
(Date:7/2/2015)... ... July 02, 2015 , ... When ... met for the late June Web-based session, the speakers discussed the importance of ... managing high-risk patients through coordinated care. , During the session, participants learned the ...
(Date:7/2/2015)... La Mirada, CA (PRWEB) , ... July 02, ... ... the addition of Dr. Divakar R. Krishnareddy, M.D., to the orthopedic and spine ... fractures, dislocations, disc herniations, sprains, strains, bursitis, and tendonitis. Along with the spine ...
(Date:7/2/2015)... ... 02, 2015 , ... Facial plastic surgery is about more ... an art and science that goes into successful facial reconstruction and contouring. Dr. ... and lives of more than 2,500 satisfied facelift and neck lift patients alone. ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder of New ... a leading international authority on the conservative treatment of back, hip, knee and ...
Breaking Medicine News(10 mins):Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4
... N.C., May 9 The cost to replace an,employee ... but the long-term cost,to the organization,s Service-Profit Chain is ... the effects of turnover on the,bottom line and offers ... tremendously improve productivity and the overall customer,experience. According to ...
... 9 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a,clinical ... of cancer therapies, today announced its 2008 ... Highlights, During the three months ended ... steps in preparation for the upcoming multi-center ...
... CCH, part of Wolters Kluwer Law,& Business, has ... Crisis: Causes and Effects of the Mortgage Meltdown, ... Wolters Kluwer Law &,Business is a leading provider ... areas for legal and business professionals., In ...
... cuts to the,Medicare physician fee schedule could severely ... rehabilitation needs of seniors and people,with disabilities -- ... according to the American Physical Therapy Association (APTA) ... 8 before a hearing of the U.S. House ...
... ... Reforms - ,Medicare for All, OAKLAND, Calif., May ... -- and the nation,s largest union of RNs,-- Bill Moyers, ... for guaranteed,single-payer healthcare in an episode scheduled to air this ...
... Women suffering with postpartum depression may in future be ... over the phone, eliminating barriers to treatment such as ... psychiatrist. , Dr. Cindy-Lee Dennis, Canada Research Chair in ... of Nursing, University of Toronto, is the lead investigator ...
Cached Medicine News:Health News:Employee Engagement & Retention: Benchmarking Metrics and Networking Opportunity to Help Solve Today's Workforce Challenges 2Health News:Bradmer announces 2008 first quarter operational and financial results 2Health News:Bradmer announces 2008 first quarter operational and financial results 3Health News:Bradmer announces 2008 first quarter operational and financial results 4Health News:Bradmer announces 2008 first quarter operational and financial results 5Health News:Bradmer announces 2008 first quarter operational and financial results 6Health News:Bradmer announces 2008 first quarter operational and financial results 7Health News:Bradmer announces 2008 first quarter operational and financial results 8Health News:CCH White Paper Details Subprime Crisis, Wider Effects 2Health News:Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress 2Health News:Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress 3Health News:Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress 4Health News:Bill Moyers' Journal to Feature California Nurses Association/National Nurses Organizing Committee in Friday, May 9th Episode 2
(Date:7/2/2015)... , July 2, 2015   BioLife Solutions , Inc. ... of proprietary clinical grade cell and tissue hypothermic storage ... cloud hosted biologistics cold chain management app for ... that Seattle Business Magazine has included BioLife in ... for in Washington state for 2015. ...
(Date:7/2/2015)... ATLANTA , July 2, 2015 Legal-Bay ... U.S. District Judge Joseph Goodwin in the ... (VA) consolidated 26 transvaginal mesh cases against Ethicon for ... nd . The cases for the 26 women include ... by a device made my Johnson & Johnson,s Ethicon ...
(Date:7/1/2015)... The Coalition of State Rheumatology Organizations ... professional rheumatology societies, today released the findings of ... of biosimilars and the potential impact of these ... are medicines that are highly similar, but not ... from generic medications in that it is impossible ...
Breaking Medicine Technology:BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 3Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2
... eCardio announced today their inclusion on the Inc. ... Inc. 500. Inc. magazine released the list on ... with a three-year sales growth of 642%. ... http://www.newscom.com/cgi-bin/prnh/20100817/INC5000LOGO ) The list represents ...
... Inc. (Nasdaq: BMRN ) announced today that ... Food and Drug Administration (FDA) for BMN-701, a novel ... (IGF2-GAA) in development for the treatment of Pompe disease. ... been submitted, investigational material has been manufactured and a ...
Cached Medicine Technology:Inc. Magazine Unveils 29th Annual List of America's Fastest-Growing Private Companies—the Inc. 500 2Inc. Magazine Unveils 29th Annual List of America's Fastest-Growing Private Companies—the Inc. 500 3BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease 2BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: